Author

K. Pavlovic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

A. Hinckley-Boned· 1 shared C. Barbero-Jimenez· 1 shared C. Grinan-Lison· 1 shared C. Herrera· 1 shared F. J. Molina-Estevez· 1 shared F. Martin· 1 shared J. A. Marchal· 1 shared J. Munoz-Ballester· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Hinckley-Boned

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

First-in-class Transactivator-Free, Doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B-cell lymphomas

P. L. Justicia-Lirio, M. Tristan-Manzano, N. Maldonado-Perez, C. Barbero-Jimenez, M. Cortijo-Gutierrez, K. Pavlovic, F. J. Molina-Estevez, P. Munoz, A. Hinckley-Boned, C. Grinan-Lison, S. A. Navarro-Marchal, J. Munoz-Ballester, P. A. Gonzalez-Sierra, C. Herrera, J. A. Marchal, F. Martin

This paper develops doxycycline-inducible IL-18 CAR-T cells (iTRUCK19.18) that enhance antitumor activity while controlling IL-18 release through dual mechanisms.

bioRxiv · Jan 23, 2024 · PreprintImmunology